Cargando…
Targeting CXCL12/CXCR4 Signaling with AMD3100 Might Selectively Suppress CXCR4+ T-Cell Chemotaxis Leading to the Alleviation of Chronic Prostatitis
BACKGROUND: Chronic nonbacterial prostatitis (CNP) has a high incidence, low cure rate, and unclear pathogenesis. Here, we aimed to systematically identify effective diagnostic and therapeutic targets for CNP. METHODS: Prostate tissues were obtained from established mouse models and negative control...
Autores principales: | Zhang, Meng, Liu, Yi, Chen, Jing, Chen, Lei, Zhang, Li, Chen, Xianguo, Hao, Zongyao, Liang, Chaozhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037856/ https://www.ncbi.nlm.nih.gov/pubmed/35479835 http://dx.doi.org/10.2147/JIR.S352336 |
Ejemplares similares
-
AMD3100/CXCR4 Inhibitor
por: De Clercq, Erik
Publicado: (2015) -
Inhibition of CXCR4–CXCL12 chemotaxis in melanoma by AMD11070
por: O'Boyle, G, et al.
Publicado: (2013) -
CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice
por: Nishimura, Yukihide, et al.
Publicado: (2011) -
CXCR4 Antagonist AMD3100 Modulates Claudin Expression and Intestinal Barrier Function in Experimental Colitis
por: Xia, Xian-Ming, et al.
Publicado: (2011) -
The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
por: Kim, Ha-Yon, et al.
Publicado: (2010)